MedPath

Xfibra, Inc.

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

A First-in-human Study of the Safety, Tolerability, and PK of XFB-19 in Healthy Adult Volunteers

Phase 1
Conditions
Idiopathic Pulmonary Fibrosis (IPF)
Interventions
Drug: Placebo
First Posted Date
2022-05-05
Last Posted Date
2022-07-19
Lead Sponsor
Xfibra, Inc.
Target Recruit Count
40
Registration Number
NCT05361733

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.